Clinical trials
Completed Phase 1 Colonic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
178 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 8 |
| 2002 | 5 |
| 2003 | 9 |
| 2004 | 9 |
| 2005 | 13 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 10 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 178 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 31 |
| Memorial Sloan Kettering Cancer Center | 16 |
| City of Hope Medical Center | 8 |
| M.D. Anderson Cancer Center | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Mayo Clinic | 4 |
| Duke University | 3 |
| Genentech, Inc. | 3 |
| NCIC Clinical Trials Group | 3 |
| National Institutes of Health Clinical Center (CC) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 178 |
| Rectal Neoplasms | 99 |
| Colorectal Neoplasms | 85 |
| Breast Neoplasms | 53 |
| Pancreatic Neoplasms | 49 |
| Carcinoma, Non-Small-Cell Lung | 36 |
| Stomach Neoplasms | 36 |
| Neoplasms | 34 |
| Lung Neoplasms | 31 |
| Prostatic Neoplasms | 27 |
Trials
Showing 1 to 25 of 178. Each trial links to its page on Pharma Observatory.
78 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.